gTLD | Full Legal Name | E-mail suffix | Detail | .ART | .ART REGISTRY INC. | afilias.info | View |
Describe proposed measures for protection of geographic names at the second and other levels in the applied-for gTLD. This should include any applicable rules and procedures for reservation and⁄or release of such names.
We will protect names with national or geographic significance by reserving the country and territory names at the second level and at all other levels within the TLD, as per the requirements in the New TLD Registry Agreement (Specification 5, paragraph 5).
We will employ a series of rules to translate the geographical names required to be reserved by Specification 5, paragraph 5 to a form consistent with the ʺhost namesʺ format used in domain names.
Considering the Governmental Advisory Committee (GAC) advice “Principles regarding new gTLDs”, these domains will be blocked, at no cost to governments, public authorities, or IGOs, before the TLD is introduced (Sunrise), so that no parties may apply for them. We will publish a list of these names before Sunrise, so our registrars and their prospective applicants can be aware that these names are reserved.
We will define a procedure so that governments can request the above reserved domain(s) if they would like to take possession of them. This procedure will be based on existing methodology developed for the release of country names in the .INFO TLD. For example, we will require a written request from the country’s GAC representative, or a written request from the country’s relevant Ministry or Department. We will allow the designated beneficiary (the Registrant) to register the name, with an accredited Afilias Registrar, possibly using an authorization number transmitted directly to the designated beneficiary in the country concerned.
As defined by Specification 5, paragraph 5, such geographic domains may be released to the extent that Registry Operator reaches agreement with the applicable government(s). Registry operator will work with respective GAC representatives of the country’s relevant Ministry of Department to obtain their release of the names to the Registry Operator.
If internationalized domains names (IDNs) are introduced in the TLD in the future, we will also reserve the IDN versions of the country names in the relevant script(s) before IDNs become available to the public. If we find it advisable and practical, we will confer with relevant language authorities so that we can reserve the IDN domains properly along with their variants.
Regarding GAC advice regarding second-level domains not specified via Specification 5, paragraph 5: All domains awarded to registrants are subject to the Uniform Domain Name Dispute Resolution Policy (UDRP), and to any properly-situated court proceeding. We will ensure appropriate procedures to allow governments, public authorities or IGO’s to challenge abuses of names with national or geographic significance at the second level. In its registry-registrar agreement, and flowing down to registrar-registrant agreements, the registry operator will institute a provision to suspend domains names in the event of a dispute. We may exercise that right in the case of a dispute over a geographic name.
gTLD | Full Legal Name | E-mail suffix | Detail | .stada | STADA Arzneimittel AG | opportunity.de | View |
STADA Arzneimittel AG will protect names with national or geographic significance by reserving the country and territory names at the second level and at all other levels within the TLD, as per the requirements in the New TLD Registry Agreement (Specification 5, paragraph 5).
STADA Arzneimittel AG will employ a series of rules to translate the geographical names required to be reserved by Specification 5, paragraph 5 to a form consistent with the ʺhost namesʺ format used in domain names.
Considering the Governmental Advisory Committee (GAC) advice “Principles regarding new gTLDs”, these domains will be blocked, at no cost to governments, public authorities, or IGOs, before the TLD is introduced (Sunrise), so that no parties may apply for them. STADA Arzneimittel AG will publish a list of these names before Sunrise, so our registrars and their prospective applicants can be aware that these names are reserved.
STADA Arzneimittel AG will define a procedure so that governments can request the above reserved domain(s) if they would like to take possession of them. This procedure will be based on existing methodology developed for the release of country names in the .INFO TLD. For example, STADA Arzneimittel AG will require a written request from the country’s GAC representative, or a written request from the country’s relevant Ministry or Department. STADA Arzneimittel AG will allow the designated beneficiary (the Registrant) to register the name, with an accredited Afilias Registrar, possibly using an authorization number transmitted directly to the designated beneficiary in the country concerned.
As defined by Specification 5, paragraph 5, such geographic domains may be released to the extent that STADA Arzneimittel AG reaches agreement with the applicable government(s). STADA Arzneimittel AG will work with respective GAC representatives of the country’s relevant Ministry of Department to obtain their release of the names to STADA Arzneimittel AG.
If internationalized domains names (IDNs) are introduced in the TLD in the future, STADA Arzneimittel AG will also reserve the IDN versions of the country names in the relevant script(s) before IDNs become available to the public. If STADA Arzneimittel AG finds it advisable and practical, STADA Arzneimittel AG will confer with relevant language authorities so that STADA Arzneimittel AG can reserve the IDN domains properly along with their variants.
Regarding GAC advice regarding second-level domains not specified via Specification 5, paragraph 5: All domains awarded to registrants are subject to the Uniform Domain Name Dispute
Resolution Policy (UDRP), and to any properly-situated court proceeding. STADA Arzneimittel AG will ensure appropriate procedures to allow governments, public authorities or IGO’s to challenge abuses of names with national or geographic significance at the second level. In its registry-registrar agreement and flowing down to registrar-registrant agreements, STADA Arzneimittel AG will institute a provision to suspend domains names in the event of a dispute. STADA Arzneimittel AG may exercise that right in the case of a dispute over a geographic name.